Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Single high dose of MVA induces a protective immune response in neonates and infants

Single high dose of MVA induces a protective immune response in neonates and infants

US Patent 9707291 · Granted Jul 18, 2017

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods and compositions for inducing protective immunity against filovirus infe2024
Multivalent recombinant modified vaccinia virus ankara (MVA) vector encoding fil2022
Methods and compositions for inducing protective immunity against filovirus infe2021
Recombinant modified vaccinia virus ankara (MVA) respiratory syncytial virus (RS2021
Recombinant modified vaccinia virus ankara (MVA) respiratory syncytial virus (RS2021
Methods and compositions for inducing protective immunity against a marburg viru2021
Use of oil and water emulsions for increasing B cell responses with modified Vac2020
Use of oil and water emulsions for increasing B cell responses with modified Vac2020
Recombinant modified vaccinia virus Ankara (MVA) multivalent filovirus immunogen2020
Methods and compositions for inducing protective immunity against filovirus infe2020
Methods and compositions for enhancing immune responses2020
Recombinant modified vaccinia virus ankara (MVA) respiratory syncytial virus (RS2020